JP7258911B2 - 気化可能な配合物 - Google Patents

気化可能な配合物 Download PDF

Info

Publication number
JP7258911B2
JP7258911B2 JP2020556897A JP2020556897A JP7258911B2 JP 7258911 B2 JP7258911 B2 JP 7258911B2 JP 2020556897 A JP2020556897 A JP 2020556897A JP 2020556897 A JP2020556897 A JP 2020556897A JP 7258911 B2 JP7258911 B2 JP 7258911B2
Authority
JP
Japan
Prior art keywords
vaporizable formulation
coolant
present
amount
vaporizable
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2020556897A
Other languages
English (en)
Japanese (ja)
Other versions
JP2021523690A (ja
Inventor
クラウス マティ，
サンチェス ペナ， マリア モントセラット
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nicoventures Trading Ltd
Original Assignee
Nicoventures Trading Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nicoventures Trading Ltd filed Critical Nicoventures Trading Ltd
Publication of JP2021523690A publication Critical patent/JP2021523690A/ja
Priority to JP2023061263A priority Critical patent/JP7682942B2/ja
Application granted granted Critical
Publication of JP7258911B2 publication Critical patent/JP7258911B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
    • A24B—MANUFACTURE OR PREPARATION OF TOBACCO FOR SMOKING OR CHEWING; TOBACCO; SNUFF
    • A24B15/00—Chemical features or treatment of tobacco; Tobacco substitutes, e.g. in liquid form
    • A24B15/10—Chemical features of tobacco products or tobacco substitutes
    • A24B15/16—Chemical features of tobacco products or tobacco substitutes of tobacco substitutes
    • A24B15/167—Chemical features of tobacco products or tobacco substitutes of tobacco substitutes in liquid or vaporisable form, e.g. liquid compositions for electronic cigarettes
    • A—HUMAN NECESSITIES
    • A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
    • A24B—MANUFACTURE OR PREPARATION OF TOBACCO FOR SMOKING OR CHEWING; TOBACCO; SNUFF
    • A24B15/00—Chemical features or treatment of tobacco; Tobacco substitutes, e.g. in liquid form
    • A24B15/18—Treatment of tobacco products or tobacco substitutes
    • A24B15/24—Treatment of tobacco products or tobacco substitutes by extraction; Tobacco extracts
    • A24B15/241—Extraction of specific substances
    • A24B15/243—Nicotine
    • A—HUMAN NECESSITIES
    • A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
    • A24B—MANUFACTURE OR PREPARATION OF TOBACCO FOR SMOKING OR CHEWING; TOBACCO; SNUFF
    • A24B15/00—Chemical features or treatment of tobacco; Tobacco substitutes, e.g. in liquid form
    • A24B15/18—Treatment of tobacco products or tobacco substitutes
    • A24B15/28—Treatment of tobacco products or tobacco substitutes by chemical substances
    • A24B15/281—Treatment of tobacco products or tobacco substitutes by chemical substances the action of the chemical substances being delayed
    • A—HUMAN NECESSITIES
    • A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
    • A24B—MANUFACTURE OR PREPARATION OF TOBACCO FOR SMOKING OR CHEWING; TOBACCO; SNUFF
    • A24B15/00—Chemical features or treatment of tobacco; Tobacco substitutes, e.g. in liquid form
    • A24B15/18—Treatment of tobacco products or tobacco substitutes
    • A24B15/28—Treatment of tobacco products or tobacco substitutes by chemical substances
    • A24B15/30—Treatment of tobacco products or tobacco substitutes by chemical substances by organic substances
    • A—HUMAN NECESSITIES
    • A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
    • A24B—MANUFACTURE OR PREPARATION OF TOBACCO FOR SMOKING OR CHEWING; TOBACCO; SNUFF
    • A24B15/00—Chemical features or treatment of tobacco; Tobacco substitutes, e.g. in liquid form
    • A24B15/18—Treatment of tobacco products or tobacco substitutes
    • A24B15/28—Treatment of tobacco products or tobacco substitutes by chemical substances
    • A24B15/30—Treatment of tobacco products or tobacco substitutes by chemical substances by organic substances
    • A24B15/32—Treatment of tobacco products or tobacco substitutes by chemical substances by organic substances by acyclic compounds
    • A—HUMAN NECESSITIES
    • A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
    • A24B—MANUFACTURE OR PREPARATION OF TOBACCO FOR SMOKING OR CHEWING; TOBACCO; SNUFF
    • A24B15/00—Chemical features or treatment of tobacco; Tobacco substitutes, e.g. in liquid form
    • A24B15/18—Treatment of tobacco products or tobacco substitutes
    • A24B15/28—Treatment of tobacco products or tobacco substitutes by chemical substances
    • A24B15/30—Treatment of tobacco products or tobacco substitutes by chemical substances by organic substances
    • A24B15/34—Treatment of tobacco products or tobacco substitutes by chemical substances by organic substances containing a carbocyclic ring other than a six-membered aromatic ring
    • A—HUMAN NECESSITIES
    • A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
    • A24B—MANUFACTURE OR PREPARATION OF TOBACCO FOR SMOKING OR CHEWING; TOBACCO; SNUFF
    • A24B15/00—Chemical features or treatment of tobacco; Tobacco substitutes, e.g. in liquid form
    • A24B15/18—Treatment of tobacco products or tobacco substitutes
    • A24B15/28—Treatment of tobacco products or tobacco substitutes by chemical substances
    • A24B15/30—Treatment of tobacco products or tobacco substitutes by chemical substances by organic substances
    • A24B15/36—Treatment of tobacco products or tobacco substitutes by chemical substances by organic substances containing a heterocyclic ring
    • A24B15/38—Treatment of tobacco products or tobacco substitutes by chemical substances by organic substances containing a heterocyclic ring having only nitrogen as hetero atom
    • A—HUMAN NECESSITIES
    • A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
    • A24B—MANUFACTURE OR PREPARATION OF TOBACCO FOR SMOKING OR CHEWING; TOBACCO; SNUFF
    • A24B15/00—Chemical features or treatment of tobacco; Tobacco substitutes, e.g. in liquid form
    • A24B15/18—Treatment of tobacco products or tobacco substitutes
    • A24B15/28—Treatment of tobacco products or tobacco substitutes by chemical substances
    • A24B15/30—Treatment of tobacco products or tobacco substitutes by chemical substances by organic substances
    • A24B15/36—Treatment of tobacco products or tobacco substitutes by chemical substances by organic substances containing a heterocyclic ring
    • A24B15/40—Treatment of tobacco products or tobacco substitutes by chemical substances by organic substances containing a heterocyclic ring having only oxygen or sulfur as hetero atoms
    • A24B15/403—Treatment of tobacco products or tobacco substitutes by chemical substances by organic substances containing a heterocyclic ring having only oxygen or sulfur as hetero atoms having only oxygen as hetero atoms
    • A24B15/406—Treatment of tobacco products or tobacco substitutes by chemical substances by organic substances containing a heterocyclic ring having only oxygen or sulfur as hetero atoms having only oxygen as hetero atoms in a five-membered ring
    • A—HUMAN NECESSITIES
    • A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
    • A24F—SMOKERS' REQUISITES; MATCH BOXES; SIMULATED SMOKING DEVICES
    • A24F40/00—Electrically operated smoking devices; Component parts thereof; Manufacture thereof; Maintenance or testing thereof; Charging means specially adapted therefor
    • A24F40/10—Devices using liquid inhalable precursors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/465—Nicotine; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M11/00—Sprayers or atomisers specially adapted for therapeutic purposes
    • A61M11/006—Sprayers or atomisers specially adapted for therapeutic purposes operated by applying mechanical pressure to the liquid to be sprayed or atomised
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00—Inhalators
    • A61M15/06—Inhaling appliances shaped like cigars, cigarettes or pipes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/34—Tobacco-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Toxicology (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Addiction (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pulmonology (AREA)
  • Hematology (AREA)
  • Anesthesiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Psychiatry (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Mechanical Engineering (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Otolaryngology (AREA)
  • Medicinal Preparation (AREA)
  • Manufacture Of Tobacco Products (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
JP2020556897A 2018-05-03 2019-05-03 気化可能な配合物 Active JP7258911B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2023061263A JP7682942B2 (ja) 2018-05-03 2023-04-05 気化可能な配合物

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB1807305.6 2018-05-03
GBGB1807305.6A GB201807305D0 (en) 2018-05-03 2018-05-03 Vaporisable formulation
PCT/GB2019/051244 WO2019211629A1 (en) 2018-05-03 2019-05-03 Vaporisable formulation

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2023061263A Division JP7682942B2 (ja) 2018-05-03 2023-04-05 気化可能な配合物

Publications (2)

Publication Number Publication Date
JP2021523690A JP2021523690A (ja) 2021-09-09
JP7258911B2 true JP7258911B2 (ja) 2023-04-17

Family

ID=62598261

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2020556897A Active JP7258911B2 (ja) 2018-05-03 2019-05-03 気化可能な配合物
JP2023061263A Active JP7682942B2 (ja) 2018-05-03 2023-04-05 気化可能な配合物

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2023061263A Active JP7682942B2 (ja) 2018-05-03 2023-04-05 気化可能な配合物

Country Status (13)

Country Link
US (1) US20210368850A1 (enExample)
EP (1) EP3787429A1 (enExample)
JP (2) JP7258911B2 (enExample)
KR (2) KR20230151065A (enExample)
CN (1) CN112074201A (enExample)
AU (2) AU2019264022A1 (enExample)
BR (1) BR112020021341A2 (enExample)
CA (2) CA3190409A1 (enExample)
GB (1) GB201807305D0 (enExample)
IL (2) IL277973B2 (enExample)
MX (1) MX2020011664A (enExample)
MY (1) MY203314A (enExample)
WO (1) WO2019211629A1 (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US12588700B2 (en) 2019-12-02 2026-03-31 Jt International Sa E-liquid composition comprising 1,3-propanediol below 50% by weight of the composition
GB202006633D0 (en) * 2020-05-05 2020-06-17 Nicoventures Holdings Ltd Aerosol generating material
US11771136B2 (en) 2020-09-28 2023-10-03 Rai Strategic Holdings, Inc. Aerosol delivery device
GB202110541D0 (en) * 2021-07-22 2021-09-08 Nicoventures Trading Ltd Delivery system
AU2022433868B2 (en) * 2022-01-14 2026-02-12 Nicoventures Trading Limited Aerosolisable material

Citations (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070144544A1 (en) 2005-09-30 2007-06-28 Cai David J Oral composition and method for stress reduction associated with smoking cessation
JP2009148233A (ja) 2007-12-21 2009-07-09 Japan Tobacco Inc 喫煙物品
JP2010513657A (ja) 2006-12-20 2010-04-30 ジボダン ネーデルランド サービシーズ ビー．ヴイ． Ｎ−置換−ｐ−メンタン−３−カルボキサミドおよびこれらの使用
US20150027454A1 (en) 2013-07-24 2015-01-29 Altria Client Services Inc. Electronic smoking article
JP2015513393A (ja) 2012-01-31 2015-05-14 アルトリア クライアント サービシーズ インコーポレイ 電子式シガレット
WO2016174137A1 (en) 2015-04-30 2016-11-03 Philip Morris Products S.A. Aerosol-generating article comprising a detachable freshener delivery element with high ventilation
JP6061900B2 (ja) 2014-07-24 2017-01-18 長谷川香料株式会社 Ｗｓ−１２の微粒子およびこれを含有する冷感剤組成物
JP2017036298A (ja) 2010-09-08 2017-02-16 ウニヴェルスィダッド ミゲル エルナンデス デ エルチェＵｎｉｖｅｒｓｉｄａｄ Ｍｉｇｕｅｌ Ｈｅｒｎａｎｄｅｚ Ｄｅ Ｅｌｃｈｅ ドライアイの治療用医薬組成物
WO2017103136A1 (en) 2015-12-18 2017-06-22 Philip Morris Products S.A. Strength enhancers and method of achieving strength enhancement in an electronic vapor device
CN106962971A (zh) 2017-04-11 2017-07-21 深圳瀚星翔科技有限公司 电子烟烟油及其制备方法
JP2018052892A (ja) 2016-09-30 2018-04-05 アース製薬株式会社 スプレー型芳香剤

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5097886A (enExample) * 1973-12-28 1975-08-04
WO2003053176A2 (en) * 2001-12-19 2003-07-03 Vector Tobacco Inc. Method and compositions for imparting cooling effect to tobacco products
US6897195B2 (en) * 2002-07-24 2005-05-24 Nanjing Zhongshi Chemical Co. Composition of menthol and menthyl lactate, its preparation method and its applications as a cooling agent
EP1835815B1 (en) * 2004-12-29 2013-08-28 Wm. Wrigley Jr. Company Combinations of cooling agents for use in confections
WO2007089652A2 (en) * 2006-01-27 2007-08-09 Cadbury Adams Usa Llc Flavor-enhancing compositions, methods of manufacture, and methods of use
JP2011520925A (ja) * 2008-05-22 2011-07-21 ジボダン エス エー 清涼組成物
DE102010002558A1 (de) * 2009-11-20 2011-06-01 Symrise Ag Verwendung physiologischer Kühlwirkstoffe und Mittel enthaltend solche Wirkstoffe
CA3208137A1 (en) * 2013-05-06 2014-11-13 Juul Labs, Inc. Nicotine salt formulations for aerosol devices and methods thereof
WO2014195872A1 (en) * 2013-06-04 2014-12-11 Vyome Biosciences Pvt. Ltd. Coated particles and compositions comprising same
US20150313275A1 (en) * 2014-04-30 2015-11-05 Altria Client Services, Inc. Liquid aerosol formulation of an electronic smoking article
GB2544468A (en) * 2015-11-12 2017-05-24 Jaytee Biosciences Ltd Liquid formulation
US20160376263A1 (en) * 2016-07-26 2016-12-29 Senomyx, Inc. Bitter taste modifiers including substituted 1-benzyl-3-(1-(isoxazol-4-ylmethyl)-1h-pyrazol-4-yl)imidazolidine-2,4-diones and compositions thereof

Patent Citations (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070144544A1 (en) 2005-09-30 2007-06-28 Cai David J Oral composition and method for stress reduction associated with smoking cessation
JP2010513657A (ja) 2006-12-20 2010-04-30 ジボダン ネーデルランド サービシーズ ビー．ヴイ． Ｎ−置換−ｐ−メンタン−３−カルボキサミドおよびこれらの使用
JP2009148233A (ja) 2007-12-21 2009-07-09 Japan Tobacco Inc 喫煙物品
JP2017036298A (ja) 2010-09-08 2017-02-16 ウニヴェルスィダッド ミゲル エルナンデス デ エルチェＵｎｉｖｅｒｓｉｄａｄ Ｍｉｇｕｅｌ Ｈｅｒｎａｎｄｅｚ Ｄｅ Ｅｌｃｈｅ ドライアイの治療用医薬組成物
JP2015513393A (ja) 2012-01-31 2015-05-14 アルトリア クライアント サービシーズ インコーポレイ 電子式シガレット
US20150027454A1 (en) 2013-07-24 2015-01-29 Altria Client Services Inc. Electronic smoking article
JP6061900B2 (ja) 2014-07-24 2017-01-18 長谷川香料株式会社 Ｗｓ−１２の微粒子およびこれを含有する冷感剤組成物
WO2016174137A1 (en) 2015-04-30 2016-11-03 Philip Morris Products S.A. Aerosol-generating article comprising a detachable freshener delivery element with high ventilation
WO2017103136A1 (en) 2015-12-18 2017-06-22 Philip Morris Products S.A. Strength enhancers and method of achieving strength enhancement in an electronic vapor device
JP2018052892A (ja) 2016-09-30 2018-04-05 アース製薬株式会社 スプレー型芳香剤
CN106962971A (zh) 2017-04-11 2017-07-21 深圳瀚星翔科技有限公司 电子烟烟油及其制备方法

Also Published As

Publication number Publication date
IL277973B1 (en) 2023-10-01
AU2022218470B2 (en) 2024-07-04
IL305868B1 (en) 2024-11-01
IL305868B2 (en) 2025-03-01
AU2019264022A1 (en) 2020-10-29
WO2019211629A1 (en) 2019-11-07
EP3787429A1 (en) 2021-03-10
NZ768771A (en) 2024-07-05
MX2020011664A (es) 2020-12-10
JP7682942B2 (ja) 2025-05-26
BR112020021341A2 (pt) 2021-01-19
IL277973B2 (en) 2024-02-01
KR20230151065A (ko) 2023-10-31
CN112074201A (zh) 2020-12-11
IL277973A (en) 2020-11-30
CA3099021A1 (en) 2019-11-07
KR102594623B1 (ko) 2023-10-25
RU2020136071A (ru) 2022-05-04
GB201807305D0 (en) 2018-06-20
JP2023085453A (ja) 2023-06-20
RU2020136071A3 (enExample) 2022-05-04
KR20200136033A (ko) 2020-12-04
CA3190409A1 (en) 2019-11-07
IL305868A (en) 2023-11-01
AU2022218470A1 (en) 2022-09-08
JP2021523690A (ja) 2021-09-09
US20210368850A1 (en) 2021-12-02
MY203314A (en) 2024-06-24

Similar Documents

Publication Publication Date Title
JP7682942B2 (ja) 気化可能な配合物
JP6731019B2 (ja) 非プロトン化型およびプロトン化型のニコチンを含む溶液
EP3703655B1 (en) Aerosolisable gel
JPWO2020202254A1 (ja) 非燃焼型加熱喫煙物品及びその使用方法、並びに非燃焼型加熱喫煙システム
ES2984536T3 (es) Formulación aerosolizable
CN114587008A (zh) 电子烟液及包含其的雾化装置
JP7618546B2 (ja) エアロゾル化可能な配合物
CN113142679A (zh) 用于气雾剂装置的尼古丁液体制剂及其方法
JP2024024046A (ja) エアロゾル化可能な配合物
JP2022506068A (ja) エアロゾル化可能な配合物
JP7041261B2 (ja) 加香された気化性配合物
WO2023008063A1 (ja) 電子タバコ用リキッド、および電子タバコ用リキッドの製造方法、ならびに電子タバコ用カートリッジ、電子タバコ
RU2772501C2 (ru) Испаряемый состав
JP2025537700A (ja) エアロゾル化可能な配合物のための消耗品
JP2025501925A (ja) エアロゾル化可能な材料
RU2806059C2 (ru) Способная образовывать аэрозоль композиция
RU2788010C2 (ru) Способная образовывать аэрозоль композиция
EP4494486A1 (en) Nicotine composition with improved stability and toxicology

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20201110

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20210709

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20220104

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20220404

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20220823

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20221115

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20230307

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20230405

R150 Certificate of patent or registration of utility model

Ref document number: 7258911

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250